Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000535578 | SCV000627873 | uncertain significance | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2017-06-19 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine with leucine at codon 959 of the FBN1 protein (p.Phe959Leu). The phenylalanine residue is moderately conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with a FBN1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, this variant has uncertain impact on FBN1 function. The available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV004802128 | SCV005424856 | uncertain significance | Marfan syndrome | 2024-03-05 | criteria provided, single submitter | clinical testing |